| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-08 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-06 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.22 | 9e-05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.18 | 9e-05 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0004 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.86 | 0.0004 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |